ArticleResearch square2025
Back to the Future: Predicting Individual Tau Progression in Alzheimer's Disease.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Alzheimer's Disease (AD) is characterized by the spread of tau neurofibrillary tangles along the brain's structural network. The marked variability in pathology spread patterns across individuals necessitates a precision medicine approach. Here we introduce Stage-based Network Diffusion (StaND), a novel algorithm that combines statistical staging with biophysical modeling to predict patient-specific tau progression. Using data from 650 subjects in the Alzheimer's Disease Neuroimaging Initiative, StaND first estimates each subject's disease stage and then infers their individual tau seeding pattern, agglomeration rate, and transmission rate. The model is applied forward in time to predict regional tau distributions cross-sectionally and longitudinally. StaND outperforms benchmark models in both instances. Inferred tau seed patterns capture spatial heterogeneity, while rate parameters explain temporal and cognitive variability. Despite diverse initial seeding patterns, tau distributions converge across subjects over time. We also identify two distinct tau seeding archetypes with distinct clinical and demographic profiles. StaND offers a powerful new approach for understanding and forecasting the spatiotemporal dynamics of AD and is widely applicable to other neurodegenerative diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.